Matthieu Leautey serves as the CEO and General Manager of Eurofins BioPharma Product Testing France, where he leverages his extensive expertise in the pharmaceutical, chemical, nuclear, and metallurgy industries to drive operational excellence and strategic growth. Under his leadership, Eurofins has established itself as a...
Matthieu Leautey serves as the CEO and General Manager of Eurofins BioPharma Product Testing France, where he leverages his extensive expertise in the pharmaceutical, chemical, nuclear, and metallurgy industries to drive operational excellence and strategic growth. Under his leadership, Eurofins has established itself as a premier service provider to pharmaceutical companies and medical device manufacturers, specializing in GMP-compliant laboratory analysis and ISO 17025 accredited services. Matthieu oversees a robust network of eight independent laboratories across France, managing seven legal entities and a dedicated workforce of 450 full-time employees, which collectively generate an impressive turnover of €60 million.
His role encompasses a broad spectrum of responsibilities, including legal, financial, and commercial oversight, ensuring that Eurofins maintains its competitive edge in a rapidly evolving market. Matthieu's strategic vision is further exemplified by his leadership in mergers and acquisitions, where he identifies and integrates opportunities that enhance the company’s capabilities and market reach. With a strong focus on continuous improvement and lean manufacturing principles, he champions initiatives that optimize supply chain management and operational processes, ultimately delivering superior value to clients.
Matthieu's deep understanding of technology transfer and change control processes positions him as a key player in navigating the complexities of the pharmaceutical landscape. His commitment to fostering a culture of operational excellence not only drives efficiency but also ensures compliance with the highest industry standards. As Eurofins BioPharma Product Testing France continues to expand its footprint, Matthieu remains dedicated to advancing the company's mission of providing innovative and reliable testing solutions that meet the evolving needs of the biopharmaceutical sector.
